Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03657511 · ClinicalTrials.gov registry record · NA
Tobacco Cessation Intervention
A NA study of Smoking, Tobacco, sponsored by Barbara Ann Karmanos Cancer Institute.
- Completed
- Registry status
- NA
- Development phase
- 100
- Enrollment target
- 1
- Study location
NCT03657511: Completed NA study of Smoking, Tobacco, sponsored by Barbara Ann Karmanos Cancer Institute.
NCT03657511 is a NA study of Smoking, Tobacco that has completed, run by Barbara Ann Karmanos Cancer Institute. The registered enrollment target is 100 participants, below the 624-participant average among 18 other Smoking, Tobacco trials with a reported enrollment target (84% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03657511, a NA study of Smoking, Tobacco, has completed, sponsored by Barbara Ann Karmanos Cancer Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is planned as an evaluation of a low cost, simple smoking cessation intervention. There is very little information about the effectiveness of a simple tobacco cessation strategy. Therefore, our objective is to obtain estimates of effectiveness that can be used to refine existing programs or to develop new ones.
Primary Outcome
Completion of second questionnaire to determine if participant is currently smoking or had quit smoking in the last 12 weeks.
Conditions Studied
Interventions
- BEHAVIORAL Educational Interventions to Promote Tobacco Cessation
Study Locations (1)
Michigan
- Barbara Ann Karmanos Cancer Institute - Detroit
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2018-10-22 |
| Est. Completion | 2021-06-21 |
| Phase | NA |
What the finished NCT03657511 record still lists
NCT03657511 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 624-participant average among 18 other Smoking, Tobacco trials with a reported enrollment target (84% lower).
The record links to 1 condition, with Smoking, Tobacco appearing as the primary indexed condition, and to 1 intervention - of which Educational Interventions to Promote Tobacco Cessation is the first listed.
NCT03657511 reports a single indexed study location in Michigan.
Frequently Asked Questions
What is clinical trial NCT03657511 about?
NCT03657511 is a clinical study titled "Tobacco Cessation Intervention". This study is planned as an evaluation of a low cost, simple smoking cessation intervention. There is very little information about the effectiveness of a simple tobacco cessation strategy. Therefore, our objective is to obtain estimates of effectiveness that can be used to refine existing programs ...
What is the current status of trial NCT03657511?
This trial is currently completed. It is a NA study. The enrollment target is 100 participants. The study started on 2018-10-22. Estimated completion is 2021-06-21.
What conditions does trial NCT03657511 study?
This clinical trial studies the following conditions: Smoking, Tobacco.
What interventions are being tested in trial NCT03657511?
The interventions under investigation include: Educational Interventions to Promote Tobacco Cessation (BEHAVIORAL).
Who is sponsoring clinical trial NCT03657511?
This trial is sponsored by Barbara Ann Karmanos Cancer Institute, which has 139 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03657511 being conducted?
This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Smoking, Tobacco
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03657511's enrollment target sits among peer trials
100 10th of 18 higher than 9 of 18 other Smoking, Tobacco trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Smoking, Tobacco trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
ACT Lung Health Intervention: Phase Two
RECRUITING · NA
-
Leveraging Community Pharmacists to Optimize Smoking Cessation Services for Rural Smokers in Appalachia
RECRUITING · NA
-
A Study Evaluating the Use of an Indoor Air Quality Monitor to Promote a Smoke-free Home
RECRUITING · NA
-
Digitally Enhanced Smoking Cessation for High Risk Smokers
ACTIVE NOT RECRUITING · NA
-
A Facebook Intervention for Young Sexual and Gender Minority Smokers
COMPLETED · NA
-
Connecting Alaska Native People to Quit Smoking
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI